Targeted Oncology16h
What's Next for Frontline Metastatic RCC Therapy
Alan Tan, MD, discusses upcoming trials that could change the landscape of frontline and adjuvant renal cell carcinoma ...
Targeted Oncology20h
Wildfires’ Impact on Patients With Cancer: Lessons in Crisis Response
The California wildfires severely affected patients with cancer, requiring evacuation protocols, community support, and ...
Targeted Oncology22h
FDA Grants 510(k) Clearance to Ibex Prostate Detect AI for Prostate Cancer
The FDA has granted a 510 (k) clearance to the Ibex Prostate Detect software (formerly Galen Second Read). The Ibex Prostate ...
Targeted Oncology22h
FDA Fast Tracks Amezalpat for HCC Treatment
Amezalpat received fast track designation from the FDA for the treatment of patients with hepatocellular carcinoma.